← Back to headlines
Novo Nordisk's Wegovy Pill Receives First European Approval for Oral Weight Loss
Novo Nordisk has expanded its franchise with the first European approval for its oral weight loss drug, Wegovy, marking a significant development in the treatment of obesity.
19 Jul, 21:31 — 19 Jul, 21:31
Sources
Showing 1 of 1 sources
